|

Precision Lung Cancer Survivorship Care Intervention

RECRUITINGN/ASponsored by Jerod L Stapleton, PhD
Actively Recruiting
PhaseN/A
SponsorJerod L Stapleton, PhD
Started2024-08-16
Est. completion2027-07-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Have been diagnosed with lung cancer
* Reside in a rural county as determined by a Rural Urban Continuum Code (RUC) of 4 or higher
* Be at least 18 years of age or older
* Be able to communicate effectively in English

Exclusion Criteria:

* Have significant psychiatric disturbance that requires a higher level of care
* Have substance abuse/dependence that requires a higher level of care
* Are participating in another lung cancer survivorship care intervention
* Have previously participated in the Kentucky LEADS Lung Cancer Survivorship Care Program

Conditions16

CancerCancer of LungCancer of the LungCancer, LungCancer, PulmonaryCancers, LungCancers, PulmonaryLung CancerLung CancersNeoplasm, Pulmonary

Locations1 site

Markey Cancer Center
Lexington, Kentucky, 40536
Jerod L Stapleton, PhDjerodstapleton@uky.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.